The Addition of Hypomethylating Agents to Low-Intensity Induction Chemotherapy Does Not Improve Outcomes in Elderly Acute Myeloid Leukemia Patients: A Single-Center Retrospective Study

<i>Background and Objectives:</i> This study aimed to evaluate whether the addition of hypomethylating agents (HMA) to low-intensity chemotherapy can enhance the clinical efficacy of induction treatment for elderly acute myeloid leukemia (AML) patients who are unsuitable for standard induction thera...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Dan Liu, Xiaoyu Wang, Juan Tong, Li Zhou, Erling Chen, Ziwei Zhou, Lei Xue, Xuhan Zhang, Guangyu Sun, Changcheng Zheng
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	MDPI AG 2023-01-01
סדרה:	Medicina
נושאים:	acute myeloid leukemia elderly patients low intensity chemotherapy hypomethylating agents complete remission survival
גישה מקוונת:	https://www.mdpi.com/1648-9144/59/1/114
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!